Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Alector, Inc. (ALEC)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alector, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Alector, Inc. since 2005.
The reporting company's ticker symbol is ALEC. The reporting company's CIK number is 1653087.
The total value of stock buying since 2005 is $15,644,600.
The total value of stock sales since 2005 is $11,921,400.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-20||Paul Robert (Chief Medical Officer)||Sale||916||16.00||14,656|
|2019-08-19||Paul Robert (Chief Medical Officer)||Sale||1,084||16.00||17,344|
|2019-08-19||King Robert (Chief Development Officer)||Sale||7,500||15.00||112,500|
|2019-08-15||Paul Robert (Chief Medical Officer)||Sale||10,000||14.19||141,900|
|2019-08-07||Orbimed Capital Llc||Sale||650,000||17.90||11,635,000|
|2019-02-11||Gordon Carl L (Director)||Buy||411,700||19.00||7,822,300|
|2019-02-11||Orbimed Capital Llc (Director)||Buy||411,700||19.00||7,822,300|
Insider trading activities including stock purchases, stock sales, and option exercises of ALEC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alector, Inc. (symbol ALEC, CIK number 1653087) see the Securities and Exchange Commission (SEC) website.